Best Biopharma Outsourcing Companies in Bavaria, Germany
The 57 best Biopharma Outsourcing companies in Bavaria, Germany in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Aenova Group.
Our analysis of 100 Biopharma Outsourcing companies
$10.3b in tracked funding; 68% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Biopharma Outsourcing companies in Bavaria
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Aenova Group CDMO offering its services for pharmaceuticals, medical devices and nutraceuticals | $113M | 76 mo ago | Acquired | — | 2008 | Cart FunctionalityCraft CMSApple iCloud Mail+15 | 4 patents Formulating and manufacturing proton pump inhibitor pharmaceutical compositions and dosage forms. | 2 job openings |
| 2 | Microcoat Provider of custom diagnostic and pharmaceutical services, including assay and product development | $1M | 66 mo ago | Funding Raised | Wolfgang Mutter Founder & Owner | 1992 | WordPressMySQLPHP+19 | 2 patents Automated detection devices for biological particles (e.g., pathogens, spores) | 3 job openings |
| 3 | Senetics Provider of regulatory support, marketing, QA services | $1M | 31 mo ago | Funding Raised | — | 2009 | WordPressMySQLPHP+26 | — | — |
| 4 | Axolabs Preclinical to commercial scale research services for developing oligonucleotide therapeutics | $947K | 68 mo ago | Funding Raised | — | 2000 | WordPressMySQLPHP+19 | 30 patents Sensitive detection technologies for oligonucleotide conjugates and nucleic acid diagnostics | — |
| 5 | Crelux X-ray crystallography, fragment based drug discovery and protein delivery. | $863K | 135 mo ago | Acquired | Michael Schaeffer Founder & Owner | 2005 | Animate.cssBootstrapApache HTTP Server+7 | — | — |
| 6 | ABJ alive Contract developer and manufacturer of natural nutritional supplements | — | 28 mo ago | Seed | Anna Jurges Founder | 2010 | — | — | — |
| 7 | Coriolis Pharma Provider of drug product development, analytical, and manufacturing services | — | 32 mo ago | Seed | — | 2008 | WordPressPleskApple iCloud Mail+29 | 27 patents Analytical methods and formulations for therapeutic antibodies and biopharma excipient stability. | 1 expansion |
| 8 | NUVISAN Provider of clinical trial supply and bioanalytical services | — | 45 mo ago | Funding Raised | — | 1979 | SitecoreZURB FoundationMicrosoft ASP.NET+18 | — | — |
Top 12 Biopharma Outsourcing companies in Bavaria
#1
Funding Raised · Ansbach, Bavaria · founded 2009 · 36 employees$1.1Mraised▾
Provider of regulatory support, marketing, QA services
- Dec 2023Grant (prize money)$180.1K
- May 2020Grant (prize money)$442.2K
- Jan 2020Grant (prize money)$445K
#2
Acquired · Starnberg, Bavaria · founded 2008 · 4200 employees$112.9Mraised▾
Aenova is a contract development and manufacturing organisation offering a range of services. The company offers its services for all standard dosage forms (solid, semi-solid and liquid) and product groups for medicinal and food supplements. Their service portfolio includes product development, including the development of formulations, preparation and packaging of clinical trial materials, coordination and organisation of clinical trials and dossier preparation for approval. Services also include production, research and development, analytical development, and supply chain management. The company operates in 27 locations in nine European countries, Asia and the USA.
- Mar 2020Conventional Debt$112.9M
- 2005PE—
#3
Funding Raised · Munich, Bavaria · founded 1992 · 213 employees$1.1Mraised▾
Provider of custom diagnostic and pharmaceutical services, including assay and product development. The company offers contract manufacturing, including protein services, solid phase coating, and lateral flow tests. Laboratory services range from early development to clinical trials and routine testing. These services include bioanalytical testing, method evaluation, and technology assessment.
- Jan 2021Grant (prize money)$433.8K
- Jun 2019Grant (prize money)$665.7K
#4
Funding Raised · Kulmbach, Bavaria · founded 2000 · 118 employees$946.6Kraised▾
Axolabs provides high-end custom research and development services in the field of oligonucleotide therapeutics. The company's expertise covers the entire value chain of oligonucleotide therapeutics including preclinical discovery, lead identification, and optimization, to biology and pharmacology, bioanalytics, formulation development, and manufacturing.
- Nov 2020Grant (prize money)$946.6K
#5
Acquired · Planegg, Bavaria · founded 2005 · 68 employees$862.8Kraised▾
Crelux, a Wuxi AppTec company is a provider of high-quality solutions for early stage drug development. Its core expertise lies in the production of prime proteins and their use in biophysical screening and protein crystallography. As a research partner, Crelux offers a portfolio of hit-finding, validation and optimization technologies along with top-level expertise in protein biochemistry. Crelux markets its services under several brand names: innovations for the production of proteins and protein complexes (PRIME PROTEINS), a selection of therapeutically relevant target proteins for X-ray crystallography (XPRESS portfolio), customised programmes for the solution of new protein structures (XPERT/XPEDITE) and technologies for fragment and compound screening and biophysical validation (INTRACT).
- Apr 2015Grant (prize money)$862.8K
#6
Seed · Bayreuth, Bavaria · founded 2010 · 3 employees—raised▾
ABJ alive GmbH is a German company that specializes in the development and manufacturing of dietary supplements, ortho-molecular products, and dietetic cuisine. Recently, NORD Holding acquired a stake in ABJ alive GmbH as part of an owner buy-out.
- Feb 2024Seed—
#7
Seed · Planegg, Bavaria · founded 2008 · 207 employees—raised▾
Provider of drug product development, analytical, and manufacturing services. The company offers formulation technologies to optimise drug stability and efficacy in vials, syringes, and cartridges. It provides analytical methods for testing and validation to meet regulatory standards. Manufacturing services include process development, troubleshooting, and therapeutic manufacturing.
- Oct 2023Seed—
#8
Funding Raised · Neu Ulm, Bavaria · founded 1979 · 1011 employees—raised▾
Provider of clinical trial supply and bioanalytical services
#9
Series A · Planegg, Bavaria · founded 2022 · 9 employees—raised▾
Provider of research, development, and manufacturing services for small molecule drugs
- Jul 2022Series A—
#10
Seed · Forchheim, Bavaria · founded 2015 · 7 employees—raised▾
Operator of a biotechnology research firm intended to create precision molecules. The company develops data science models to predict molecular properties to accelerate the drug and compound discovery process, enabling scientists to create better molecules faster.
- May 2022Seed—
#11
Unfunded · Munich, Bavaria · founded 1999 · 1509 employees—raised▾
Wacker Chemie AG manufactures and sells chemicals and silicon-based products. The firm organizes itself into four segments based on product type. The Wacker Silicones segment, which generates the most revenue of any segment, sells silicon- and methanol-based products, including durable insulators, lubricants, and sealants. The Wacker Polymers segment provides chemical binders and additives used in construction industry products. The Wacker Biosolutions segment sells chemicals to the pharmaceutical and agrochemical industries. The Wacker Polysilicon segment sells material for solar power and semiconductors. The majority of revenue comes from Europe, China, India, and South Korea.
#12
Series A · Edling, Bavaria · founded 2002 · 168 employees—raised▾
Denava is a family holding company in the field of health and digital sectors. The company's portfolio has investments in GoCaps, Goerlich Pharma, NAVAGOtech, PG-Naturpharma, and Creaded.
- 2012Series A—
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Biopharma Outsourcing coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Germany
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,297 Germany-affiliated papers.
- Heidelberg University85
- German Cancer Research Center49
- Ludwig-Maximilians-Universität München48
- Technical University of Munich43
- Karlsruhe Institute of Technology33
- Gene3→29
- Mutant3→19
- Transcription (linguistics)3→16
- Messenger RNA1→14
- Immune system1→12
- Gene3→20
- Agriculture2→12
- Extracellular1→11
- Immune system1→11
- Transcriptome1→9
- Antibiotic resistance2→9
- Gene1→7
- Agriculture4→9
- Antimicrobial1→4
- Microbiome1→4
Where biotechnology is researched across Germany
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Germany
Germany biotechnology patent filing is cooling — 53,233 filings from 8,000 assignees (2016–2025), led by Immatics Biotechnologies, BASF Plant Science, BASF SE; annual filings 4819→4267.
- Immatics Biotechnologies4875
- BASF Plant Science4000
- BASF SE3548
- Boehringer Ingelheim INT3441
- Merck Patent3137
- MAX Planck Gesellschaft1805
- Evonik Degussa1684
- Amgen RES Munich1665
Common questions
Riya reads income statements for fun. She covers the real money in a sector — revenue, growth, who actually earns — and never met a vague claim she didn't want a number for.